Jonathan Poole
2015 - Genocea Biosciences
In 2015, Jonathan Poole earned a total compensation of $1.1M as Chief Financial Officer at Genocea Biosciences, a 67% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $115,360 |
---|---|
Option Awards | $620,360 |
Salary | $328,000 |
Other | $7,295 |
Total | $1,071,015 |
Poole received $620.4K in option awards, accounting for 58% of the total pay in 2015.
Poole also received $115.4K in non-equity incentive plan, $328K in salary and $7.3K in other compensation.
Rankings
In 2015, Jonathan Poole's compensation ranked 7,613th out of 13,638 executives tracked by ExecPay. In other words, Poole earned more than 44.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,613 out of 13,638 | 44th |
Division Manufacturing | 2,888 out of 5,190 | 44th |
Major group Chemicals And Allied Products | 1,045 out of 1,854 | 44th |
Industry group Drugs | 842 out of 1,528 | 45th |
Industry Biological Products, Except Diagnostic Substances | 142 out of 254 | 44th |
Source: SEC filing on April 21, 2017.
Poole's colleagues
We found two more compensation records of executives who worked with Jonathan Poole at Genocea Biosciences in 2015.